Experimental study demonstrates Far UV-C rapidly inactivates multidrug-resistant pathogens on common hospital surfaces, highlighting its potential for continuous, safe clinical decontamination.
Contact with contaminated surfaces is an important route of transmission for healthcare-associated infections. Far UV-C is a novel technology that shows promise for surface disinfection. Rigorous testing suggests Far UV-C is not hazardous to humans when used within exposure limits, making it a safer alternative to conventional germicidal UV-C. We conducted Far UV-C disinfection experiments of common hospital surfaces seeded with healthcare-associated pathogens. Far UV-C doses of 17.5 mJ/cm2 or lower resulted in a 2 log10 (99%) reduction in Klebsiella pneumoniae, Acinetobacter baumannii, Enterococcus faecium, and Enterobacter cloacae on stainless-steel, acrylic, and tile surfaces. Both Weibull and biphasic models describe the inactivation kinetics (0.882 ≤ R2 ≤ 0.99). UV sensitivity was largely species-dependent but independent of material type. Our findings support Far UV-C as an effective disinfection method for diverse hospital surfaces and can inform future implementation.
No takes yet. Share an insight, caveat, or question.
Caroline Elliott Butler (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: